AAO: Normal-tension glaucoma tied to higher Alzheimer’s disease risk
Oct 12, 2022
The authors say that people with normal-tension glaucoma should be screened for Alzheimer’s disease.
Biden makes another push for cancer moonshot initiative
Sep 13, 2022
The president likened JFK’s space race to his own effort to slash cancer rates by 50% in the next 25 years.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
Trial begins of nasal vaccine for Alzheimer’s disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
Cataract surgeries down in those with Alzheimer’s disease diagnosis
Jun 04, 2021
Authors say patients with Alzheimer’s disease still would be expected to benefit from cataract surgery.
House committees to investigate new Alzheimer’s disease drug approval
Jul 01, 2021
The FDA approved aducanumab earlier this month, despite advisory committee’s conclusion that there was not enough evidence to support its effectiveness.
Alzheimer’s, Parkinson’s disease share protective association at HLA locus
Sep 08, 2023
Protective HLA-DRB1*04 subtypes bind strongly to aggregation-prone tau PHF6 sequence when acetylated at K311.
Senate committee backs Califf nomination to head FDA
Jan 14, 2022
Among those who voted against Califf’s nomination were Democrats who expressed concerns about his links to pharmaceutical companies.
Alzheimer’s disease risk up for older adults after COVID-19 infection
Sep 14, 2022
The highest risk for a new diagnosis of Alzheimer’s disease within 360 days after diagnosis was seen for those aged 85 years and older and women.